Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Single Doses of GZC8072 Tablets in Healthy Adult Participants and to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Multiple Doses in Participants With Overweight or Obesity

NCT07784699 is registered in ClinicalTrials.gov with Gan & Lee Pharmaceuticals. as lead sponsor.

NCT NCT07784699
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07784699 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Single Doses of GZC8072 Tablets in Healthy Adult Participants and to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Multiple Doses in Participants With Overweight or Obesity
Lead sponsor
Gan & Lee Pharmaceuticals.
Phase
Phase 1
Overall status
Recruiting
Start date
September 2, 2026
Completion date
August 18, 2027
Enrollment
126 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects;overweight or obesity